Lucas Schirmer

Prof. Dr. Lucas Schirmer

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2017 in Nature
Verified
Journal Article
Closed access
PDF file
SLShane Liddelow
Shane Liddelow
KGKevin A. Guttenplan
Kevin A. Guttenplan
LCLaura E. Clarke
Laura E. Clarke
FBFrederick C. Bennett
Frederick C. Bennett
CBChristopher J. Bohlen
Christopher J. Bohlen
BBBen A. Barres
Ben A. Barres

17 May 2019 in Science
Verified
Journal Article
Open access
PDF file
DVDmitry Velmeshev
Dmitry Velmeshev
LSLucas Schirmer
Lucas Schirmer
DJDiane Jung
Diane Jung
MHMaximilian Haeussler
Maximilian Haeussler
YPYonatan Perez
Yonatan Perez
AKArnold R. Kriegstein
Arnold R. Kriegstein
Brain cell transcriptomes in autism: Autism manifests in many ways. Despite that diversity, the disorder seems to affect specific cellular pathways, including those observed in the neocortex of patients' brains. Velmeshev et al. analyzed the transcriptomes of single brain cells, including neurons and glia, from patients with autism. Single-nucleus RNA sequencing analysis suggested that affected pathways regulate synapse function as well as neural outgrowth and migration. Furthermore, in patient samples, specific sets of genes enriched in upper-layer projection neurons and microglia correlated with clinical severity. Science , this issue p. 685

17 July 2019 in Nature
Verified
Journal Article
Closed access
PDF file
LSLucas Schirmer
Lucas Schirmer
DVDmitry Velmeshev
Dmitry Velmeshev
SHStaffan Holmqvist
Staffan Holmqvist
MKMax Kaufmann
Max Kaufmann
SWSebastian Werneburg
Sebastian Werneburg
DRDavid H. Rowitch
David H. Rowitch

12 July 2012 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
RSRajneesh Srivastava
Rajneesh Srivastava
MAMuhammad Aslam
Muhammad Aslam
SKSudhakar Reddy Kalluri
Sudhakar Reddy Kalluri
LSLucas Schirmer
Lucas Schirmer
DBDorothea Buck
Dorothea Buck
BHBernhard Hemmer
Bernhard Hemmer
Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system. Many findings suggest that the disease has an autoimmune pathogenesis; the target of the immune response is not yet known. We screened serum IgG from persons with multiple sclerosis to identify antibodies that are capable of binding to brain tissue and observed specific binding of IgG to glial cells in a subgroup of patients. Using a proteomic approach focusing on membrane proteins, we identified the ATP-sensitive inward rectifying potassium channel KIR4.1 as the target of the IgG antibodies. We used a multifaceted validation strategy to confirm KIR4.1 as a target of the autoantibody response in multiple sclerosis and to show its potential pathogenicity in vivo. Serum levels of antibodies to KIR4.1 were higher in persons with multiple sclerosis than in persons with other neurologic diseases and healthy donors (P<0.001 for both comparisons). We replicated this finding in two independent groups of persons with multiple sclerosis or other neurologic diseases (P<0.001 for both comparisons). Analysis of the combined data sets indicated the presence of serum antibodies to KIR4.1 in 186 of 397 persons with multiple sclerosis (46.9%), in 3 of 329 persons with other neurologic diseases (0.9%), and in none of the 59 healthy donors. These antibodies bound to the first extracellular loop of KIR4.1. Injection of KIR4.1 serum IgG into the cisternae magnae of mice led to a profound loss of KIR4.1 expression, altered expression of glial fibrillary acidic protein in astrocytes, and activation of the complement cascade at sites of KIR4.1 expression in the cerebellum. KIR4.1 is a target of the autoantibody response in a subgroup of persons with multiple sclerosis. (Funded by the German Ministry for Education and Research and Deutsche Forschungsgemeinschaft.)

1 July 2016 in Stroke
Verified
Journal Article
Closed access
PDF file
TBTobias Boeckh-Behrens
Tobias Boeckh-Behrens
JKJustus F. Kleine
Justus F. Kleine
CZClaus Zimmer
Claus Zimmer
FNFrauke Neff
Frauke Neff
FSFabian Scheipl
Fabian Scheipl
HPHolger Poppert
Holger Poppert
Background and Purpose—: Ischemic stroke of undetermined cause is a major health issue because of its high frequency and clinical relevance. Histopathologic analysis of human thrombi, retrieved from stroke patients with large-vessel occlusion during mechanical thrombectomy, may provide information about underlying pathologies. This study examines the relationship between stroke causes and histological clot composition to identify specific patterns that might help to distinguish causes of cryptogenic stroke. Methods—: Thrombi of 145 consecutive stroke patients with large-vessel occlusion were collected during intracranial mechanical recanalization. The hematoxylin and eosin–stained specimens were quantitatively analyzed in terms of the relative fractions of the main constituents (red and white blood cells and fibrin/platelets). These data, along with additional clinical and interventional parameters, were compared for different stroke subtypes, as defined by the international Trial of Org 10172 in Acute Stroke Treatment criteria. Results—: The composition of thrombi from cardioembolic and noncardioembolic stroke patients differed significantly for all main thrombus components. Cardioembolic thrombi had higher proportions of fibrin/platelets ( P =0.009), less erythrocytes ( P =0.003), and more leucocytes ( P =0.035) than noncardioembolic thrombi. Cryptogenic strokes showed strong overlap with cardioembolic strokes but not with noncardioembolic strokes, in terms of both thrombus histology and interventional and clinical outcome parameters. Conclusions—: Quantitative evaluation of thrombus composition may help to distinguish between different stroke causes. Our findings support the notion that the majority of cryptogenic strokes are cardioembolic.

13 October 2023 in Science
Verified
Journal Article
Closed access
DVDmitry Velmeshev
Dmitry Velmeshev
YPYonatan Perez
Yonatan Perez
ZYZihan Yan
Zihan Yan
JVJonathan E. Valencia
Jonathan E. Valencia
DCDavid R. Castaneda-Castellanos
David R. Castaneda-Castellanos
AKArnold R. Kriegstein
Arnold R. Kriegstein
We analyzed >700,000 single-nucleus RNA sequencing profiles from 106 donors during prenatal and postnatal developmental stages and identified lineage-specific programs that underlie the development of specific subtypes of excitatory cortical neurons, interneurons, glial cell types, and brain vasculature. By leveraging single-nucleus chromatin accessibility data, we delineated enhancer gene regulatory networks and transcription factors that control commitment of specific cortical lineages. By intersecting our results with genetic risk factors for human brain diseases, we identified the cortical cell types and lineages most vulnerable to genetic insults of different brain disorders, especially autism. We find that lineage-specific gene expression programs up-regulated in female cells are especially enriched for the genetic risk factors of autism. Our study captures the molecular progression of cortical lineages across human development.